107 related articles for article (PubMed ID: 19881252)
21. Evaluation of the concentration of marbofloxacin in alveolar macrophages and pulmonary epithelial lining fluid after administration in dogs.
Boothe HW; Jones SA; Wilkie WS; Boeckh A; Stenstrom KK; Boothe DM
Am J Vet Res; 2005 Oct; 66(10):1770-4. PubMed ID: 16273909
[TBL] [Abstract][Full Text] [Related]
22. In Vitro and in Silico Tools To Assess Extent of Cellular Uptake and Lysosomal Sequestration of Respiratory Drugs in Human Alveolar Macrophages.
Ufuk A; Assmus F; Francis L; Plumb J; Damian V; Gertz M; Houston JB; Galetin A
Mol Pharm; 2017 Apr; 14(4):1033-1046. PubMed ID: 28252969
[TBL] [Abstract][Full Text] [Related]
23. Comparison of Plasma and Intrapulmonary Concentrations of Nafithromycin (WCK 4873) in Healthy Adult Subjects.
Rodvold KA; Gotfried MH; Chugh R; Gupta M; Friedland HD; Bhatia A
Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28696231
[TBL] [Abstract][Full Text] [Related]
24. Efficient drug delivery to alveolar macrophages and lung epithelial lining fluid following pulmonary administration of liposomal ciprofloxacin in rats with pneumonia and estimation of its antibacterial effects.
Chono S; Tanino T; Seki T; Morimoto K
Drug Dev Ind Pharm; 2008 Oct; 34(10):1090-6. PubMed ID: 18777242
[TBL] [Abstract][Full Text] [Related]
25. Meropenem-RPX7009 Concentrations in Plasma, Epithelial Lining Fluid, and Alveolar Macrophages of Healthy Adult Subjects.
Wenzler E; Gotfried MH; Loutit JS; Durso S; Griffith DC; Dudley MN; Rodvold KA
Antimicrob Agents Chemother; 2015 Dec; 59(12):7232-9. PubMed ID: 26349830
[TBL] [Abstract][Full Text] [Related]
26. Pharmacokinetic modelling of serum and bronchial concentrations for clarithromycin and telithromycin, and site-specific pharmacodynamic simulation for their dosages.
Ikawa K; Kikuchi E; Kikuchi J; Nishimura M; Derendorf H; Morikawa N
J Clin Pharm Ther; 2014 Aug; 39(4):411-7. PubMed ID: 24661290
[TBL] [Abstract][Full Text] [Related]
27. Pharmacodynamic activity of telithromycin against macrolide-susceptible and macrolide-resistant Streptococcus pneumoniae simulating clinically achievable free serum and epithelial lining fluid concentrations.
Zhanel GG; Johanson C; Hisanaga T; Mendoza C; Laing N; Noreddin A; Wierzbowski A; Hoban DJ
J Antimicrob Chemother; 2004 Dec; 54(6):1072-7. PubMed ID: 15531596
[TBL] [Abstract][Full Text] [Related]
28. Flow cytometric detection of cell-associated interleukin-8 in alveolar macrophages in vivo from patients with hypersensitivity pneumonitis and sarcoidosis.
Fujishima S; Nakamura M; Nakamura H; Inoue T; Yogo Y; Okubo Y; Aikawa N; Kanazawa M; Yamaguchi K
Scand J Clin Lab Invest; 2004; 64(3):237-43. PubMed ID: 15222634
[TBL] [Abstract][Full Text] [Related]
29. Lung concentrations of telithromycin after oral dosing.
Khair OA; Andrews JM; Honeybourne D; Jevons G; Vacheron F; Wise R
J Antimicrob Chemother; 2001 Jun; 47(6):837-40. PubMed ID: 11389116
[TBL] [Abstract][Full Text] [Related]
30. Biopharmaceutical characterization of nebulized antimicrobial agents in rats: 1. Ciprofloxacin, moxifloxacin, and grepafloxacin.
Gontijo AV; Brillault J; Grégoire N; Lamarche I; Gobin P; Couet W; Marchand S
Antimicrob Agents Chemother; 2014 Jul; 58(7):3942-9. PubMed ID: 24798283
[TBL] [Abstract][Full Text] [Related]
31. Active uptake of ulifloxacin from plasma to lung that controls its concentration in epithelial lining fluid.
Aoki M; Iguchi M; Hayashi H; Shibasaki S; Kurosawa T; Hayashi M
Biol Pharm Bull; 2009 Jun; 32(6):1095-100. PubMed ID: 19483322
[TBL] [Abstract][Full Text] [Related]
32. Uptake characteristics of liposomes by rat alveolar macrophages: influence of particle size and surface mannose modification.
Chono S; Tanino T; Seki T; Morimoto K
J Pharm Pharmacol; 2007 Jan; 59(1):75-80. PubMed ID: 17227623
[TBL] [Abstract][Full Text] [Related]
33. Nitric oxide production by rat bronchoalveolar macrophages or polymorphonuclear leukocytes following intratracheal instillation of lipopolysaccharide or silica.
Huffman LJ; Prugh DJ; Millecchia L; Schuller KC; Cantrell S; Porter DW
J Biosci; 2003 Feb; 28(1):29-37. PubMed ID: 12682422
[TBL] [Abstract][Full Text] [Related]
34. Pharmacokinetics of azithromycin in serum, bronchial washings, alveolar macrophages and lung tissue following a single oral dose of extended or immediate release formulations of azithromycin.
Lucchi M; Damle B; Fang A; de Caprariis PJ; Mussi A; Sanchez SP; Pasqualetti G; Del Tacca M
J Antimicrob Chemother; 2008 Apr; 61(4):884-91. PubMed ID: 18252692
[TBL] [Abstract][Full Text] [Related]
35. Gender differences in nitric oxide production by alveolar macrophages in ethanol plus lipopolysaccharide-treated rats.
Spitzer JA
Nitric Oxide; 1997 Feb; 1(1):31-8. PubMed ID: 9701042
[TBL] [Abstract][Full Text] [Related]
36. Long-lasting production of TGF-beta1 by alveolar macrophages exposed to low doses of asbestos without apoptosis.
Nishimura Y; Nishiike-Wada T; Wada Y; Miura Y; Otsuki T; Iguchi H
Int J Immunopathol Pharmacol; 2007; 20(4):661-71. PubMed ID: 18179739
[TBL] [Abstract][Full Text] [Related]
37. Aerosol-based efficient delivery of azithromycin to alveolar macrophages for treatment of respiratory infections.
Togami K; Chono S; Morimoto K
Pharm Dev Technol; 2013; 18(6):1361-5. PubMed ID: 22812381
[TBL] [Abstract][Full Text] [Related]
38. Assessing toxicity of fine and nanoparticles: comparing in vitro measurements to in vivo pulmonary toxicity profiles.
Sayes CM; Reed KL; Warheit DB
Toxicol Sci; 2007 May; 97(1):163-80. PubMed ID: 17301066
[TBL] [Abstract][Full Text] [Related]
39. Disposition of oral telithromycin in foals and in vitro activity of the drug against macrolide-susceptible and macrolide-resistant Rhodococcus equi isolates.
Javsicas LH; Giguère S; Womble AY
J Vet Pharmacol Ther; 2010 Aug; 33(4):383-8. PubMed ID: 20646201
[TBL] [Abstract][Full Text] [Related]
40. Regulation of alveolar macrophage and type II cell DNA synthesis: effects of ozone inhalation.
Prokhorova S; Patel N; Laskin DL
Am J Physiol; 1998 Dec; 275(6):L1200-7. PubMed ID: 9843858
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
